The average one-year price target for Bionano Genomics (NasdaqCM:BNGO) has been revised to $7.65 / share. This is a decrease of 21.05% from the prior estimate of $9.69 dated November 14, 2025. The ...

Total Revenue-- $7.4 million in 2025, a 21% increase over 2024, with core revenue up 12% after adjusting for a $500,000 write-down in discontinued clinical services in 2024. Flow Cells Sold-- 8,390 ...

Bionano Genomics, Inc. (NASDAQ:BNGO) is among the best fundamentally strong penny stocks to buy right now. Bionano Genomics, Inc. (NASDAQ:BNGO) has launched a public offering of 5 million shares, ...

SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the closing of its previously announced public offering of an aggregate ...

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the pricing of a public offering of an aggregate of 5,000,000 shares of ...

Bionano Genomics shares were 38% lower, at $1.72, after the company priced a public offering of 5 million shares, Series E warrants to buy up to 5 million shares, and short-term Series F warrants to ...

U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday. The Dow traded down 0.37% to 45,713.02 while the NASDAQ fell 0.03% to ...

Operator: Good day, and welcome to the Bionano Second Quarter 2025 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Kelly Gura ...

Total revenue (GAAP) was $6.73 million for Q2 2025, down 13% year over year (GAAP), but exceeded analyst estimates by 2.6% (GAAP). Gross margin (GAAP) expanded to 52% in Q2 2025, up from 35% in Q2 ...

Bionano Genomics BNGO is set to give its latest quarterly earnings report on Thursday, 2025-08-14. Here's what investors need to know before the announcement. Analysts estimate that Bionano Genomics ...